These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Luteolin is a rare substrate of human catechol-O-methyltransferase favoring a para-methylation. Chen ZJ, Dai YQ, Kong SS, Song FF, Li LP, Ye JF, Wang RW, Zeng S, Zhou H, Jiang HD. Mol Nutr Food Res; 2013 May; 57(5):877-85. PubMed ID: 23386290 [Abstract] [Full Text] [Related]
3. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation. Palma PN, Rodrigues ML, Archer M, Bonifácio MJ, Loureiro AI, Learmonth DA, Carrondo MA, Soares-da-Silva P. Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795 [Abstract] [Full Text] [Related]
17. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease. Patel CN, Georrge JJ, Modi KM, Narechania MB, Patel DP, Gonzalez FJ, Pandya HA. J Biomol Struct Dyn; 2018 Nov 24; 36(15):3938-3957. PubMed ID: 29281938 [Abstract] [Full Text] [Related]
18. Theoretical modeling of enzyme catalytic power: analysis of "cratic" and electrostatic factors in catechol O-methyltransferase. Roca M, Martí S, Andrés J, Moliner V, Tuñón I, Bertrán J, Williams IH. J Am Chem Soc; 2003 Jun 25; 125(25):7726-37. PubMed ID: 12812514 [Abstract] [Full Text] [Related]